Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

History of the restoration of adenovirus type 4 and type 7 vaccine, live oral (Adenovirus Vaccine) in the context of the Department of Defense acquisition system.

Hoke CH Jr, Snyder CE Jr.

Vaccine. 2013 Mar 15;31(12):1623-32. doi: 10.1016/j.vaccine.2012.12.029. Epub 2013 Jan 3.

PMID:
23291475
3.

Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004.

Russell KL, Hawksworth AW, Ryan MA, Strickler J, Irvine M, Hansen CJ, Gray GC, Gaydos JC.

Vaccine. 2006 Apr 5;24(15):2835-42. Epub 2006 Jan 24.

4.

Adult adenovirus infections: loss of orphaned vaccines precipitates military respiratory disease epidemics. For the Adenovirus Surveillance Group.

Gray GC, Goswami PR, Malasig MD, Hawksworth AW, Trump DH, Ryan MA, Schnurr DP.

Clin Infect Dis. 2000 Sep;31(3):663-70. Epub 2000 Oct 4.

PMID:
11017812
5.

High isolation rate of adenovirus serotype 7 from South Korean military recruits with mild acute respiratory disease.

Jeon K, Kang CI, Yoon CH, Lee DJ, Kim CH, Chung YS, Kang C, Choi CM.

Eur J Clin Microbiol Infect Dis. 2007 Jul;26(7):481-3.

PMID:
17541654
6.

Spread of adenovirus to geographically dispersed military installations, May-October 2007.

Trei JS, Johns NM, Garner JL, Noel LB, Ortman BV, Ensz KL, Johns MC, Bunning ML, Gaydos JC.

Emerg Infect Dis. 2010 May;16(5):769-75. doi: 10.3201/eid1605.091633.

7.

Two fatal cases of adenovirus-related illness in previously healthy young adults--Illinois, 2000.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2001 Jul 6;50(26):553-5.

8.

Challenges associated with the emergence of adenovirus type 14 at US military training centers.

Neville JS, Bunning M, Lyons A, Russell K, Faix D, Blaessing C, Johns N, Gaydos J.

Mil Med. 2008 Jul;173(7):iv-vii. No abstract available. Erratum in: Mil Med. 2008 Sep;173(9):824. Bunning, Michel [added]; Lyons, Arthur [added]; Russell, Kevin [added]; Faix, Dennis [added]; Blaessing, Carl [added]; Johns, Natalie [added]; Gaydos, Joel [added].

PMID:
18700589
9.

Adenovirus vaccines in the U.S. military.

Gaydos CA, Gaydos JC.

Mil Med. 1995 Jun;160(6):300-4.

PMID:
7659229
10.

Control of adenovirus acute respiratory disease in U.S. Army trainees.

Top FH Jr.

Yale J Biol Med. 1975 Jul;48(3):185-95. Review.

11.

Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007.

Tate JE, Bunning ML, Lott L, Lu X, Su J, Metzgar D, Brosch L, Panozzo CA, Marconi VC, Faix DJ, Prill M, Johnson B, Erdman DD, Fonseca V, Anderson LJ, Widdowson MA.

J Infect Dis. 2009 May 15;199(10):1419-26. doi: 10.1086/598520.

PMID:
19351260
12.

Cost-effectiveness analysis of reacquiring and using adenovirus types 4 and 7 vaccines in naval recruits.

Hyer RN, Howell MR, Ryan MA, Gaydos JC.

Am J Trop Med Hyg. 2000 May;62(5):613-8.

PMID:
11289673
13.
14.

A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits.

Kuschner RA, Russell KL, Abuja M, Bauer KM, Faix DJ, Hait H, Henrick J, Jacobs M, Liss A, Lynch JA, Liu Q, Lyons AG, Malik M, Moon JE, Stubbs J, Sun W, Tang D, Towle AC, Walsh DS, Wilkerson D; Adenovirus Vaccine Efficacy Trial Consortium.

Vaccine. 2013 Jun 19;31(28):2963-71. doi: 10.1016/j.vaccine.2013.04.035. Epub 2013 Apr 25.

PMID:
23623865
15.

Large epidemic of respiratory illness due to adenovirus types 7 and 3 in healthy young adults.

Ryan MA, Gray GC, Smith B, McKeehan JA, Hawksworth AW, Malasig MD.

Clin Infect Dis. 2002 Mar 1;34(5):577-82. Epub 2002 Jan 16.

PMID:
11803503
16.

Adenovirus serotype 14 pneumonia at a basic military training site in the United States, spring 2007: a case series.

Brosch L, Tchandja J, Marconi V, Rasnake M, Prakash V, McKnight T, Bunning M.

Mil Med. 2009 Dec;174(12):1295-9.

PMID:
20055071
17.

Epidemic spread of adenovirus type 4-associated acute respiratory disease between U.S. Army installations.

McNeill KM, Ridgely Benton F, Monteith SC, Tuchscherer MA, Gaydos JC.

Emerg Infect Dis. 2000 Jul-Aug;6(4):415-9.

18.

Prevalence of antibodies to adenovirus serotypes 4 and 7 among unimmunized US Army trainees: results of a retrospective nationwide seroprevalence survey.

Ludwig SL, Brundage JF, Kelley PW, Nang R, Towle C, Schnurr DP, Crawford-Miksza L, Gaydos JC.

J Infect Dis. 1998 Dec;178(6):1776-8.

PMID:
9815232
19.

Emergence of adenovirus type 14 in US military recruits--a new challenge.

Binn LN, Sanchez JL, Gaydos JC.

J Infect Dis. 2007 Nov 15;196(10):1436-7. Epub 2007 Oct 31. No abstract available.

PMID:
18008220
20.

Dramatic decline of respiratory illness among US military recruits after the renewed use of adenovirus vaccines.

Radin JM, Hawksworth AW, Blair PJ, Faix DJ, Raman R, Russell KL, Gray GC.

Clin Infect Dis. 2014 Oct;59(7):962-8. doi: 10.1093/cid/ciu507. Epub 2014 Jul 2.

PMID:
24991024

Supplemental Content

Support Center